4
Shared Docs
4
Same-Page
4 / 4
Mentions
nistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy tests on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as synopses of data from clinical trials, the communic
c interest in the outcome of the matter. Example I to paragraph (j): An attorney participated in preparing the Government's antitrust action against Z Company. After leaving the Government, she may not represent Z Company in a private antitrust action brought against it by X Company on the same facts invo
nistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy tests on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as synopses of data from clinical trials, the communic
c interest in the outcome of the matter. Example I to paragraph (j): An attorney participated in preparing the Government's antitrust action against Z Company. After leaving the Government, she may not represent Z Company in a private antitrust action brought against it by X Company on the same facts invo
inistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy test on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as syncpses of data from clinical trials, the communic
ic interest in the outcome of the matter. Example l to paragraph (9: An attorney participated in preparing the Government's antitrust action against Z Company. After leaving the Government, site may not represent Z Company in a private antitrust action brought against it by X Company on the same facts inv
inistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy test on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as syncpses of data from clinical trials, the communic
ic interest in the outcome of the matter. Example l to paragraph (9: An attorney participated in preparing the Government's antitrust action against Z Company. After leaving the Government, site may not represent Z Company in a private antitrust action brought against it by X Company on the same facts inv
Entities connected to both ABC Drug Co. and Z Company

Jeffrey Epstein
PERSON
the Board of Directors
ORGANIZATIONCompany A
ORGANIZATION
the National Institutes of Health
ORGANIZATIONthe Southern District
LOCATIONPost-Employment Conflict of Interest Restrictions
ORGANIZATIONthe National Endowment for the Humanities
ORGANIZATIONthe Administration for Children and Families
ORGANIZATIONABC Company
ORGANIZATIONthe Bureau of Land Management
ORGANIZATION
Supreme Court
ORGANIZATIONthe Agency for Health Care Policy
ORGANIZATIONXYZ Architectural Associates
ORGANIZATIONGood Foods, Inc.
ORGANIZATIONthe Department of the Army
ORGANIZATIONMunitions, Inc.
ORGANIZATIONU.S. Customs
ORGANIZATION
Federal Trade Commission
ORGANIZATION
Maine
LOCATIONFederal Government
ORGANIZATION